|
Dr. Williams is one of the founders of Orapharma, Inc. which successfully completed a $76 million IPO in 2000 and was subsequently purchased by Johnson & Johnson for approximately $85 million, net of cash, in 2003. Dr. Williams is Straumann Distinguished Professor and Chairman of the Department of Periodontology at the University of North Carolina School of Dentistry at Chapel Hill. He received his DMD (with honors) from the University of Alabama School of Dentistry and his certificate in Periodontology and Oral Medicine from the Harvard School of Dental Medicine. He was also a Postdoctoral Fellow in Microbiology at Forsyth Dental Center. >From 1974 to 1994 Dr. Williams was a member of the faculty of the Harvard School of Dental Medicine where from 1981 to 1994 he was Graduate Program Director and from 1983 to 1994 he was Head of the Department of Periodontology. Dr. Williams was also Associate Dean for Postdoctoral Education from 1989-1994. In 1994 he was appointed Professor and Chair of the Department of Periodontology at UNC-Chapel Hill. His major research interests include: pharmacologic interception of the progression of periodontal disease, the risk for periodontitis, periodontitis as a risk for systemic conditions and wound healing around teeth and around dental implants. Dr. Williams has authored over 200 papers and abstracts on his work. He lectures nationally and internationally each year. As an educator, Dr. Williams has trained over 120 women and men in the specialty of Periodontics who have gone on to assume positions of leadership in private practice, academia and industry. In 2004, he received the American Academy of Periodontology’s Outstanding Educator Award. | 